http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101555548-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101555548-B1 |
| titleOfInvention | A New Antibody Fragment for EGFR |
| abstract | The present invention relates to a novel protein capable of specifically binding to epidermal growth factor receptor (EGFR). The present invention also relates to a pharmaceutical composition for cancer therapy or a composition for cancer diagnosis comprising the protein. The protein of the present invention is superior in binding ability to EGFR as compared with conventional antibody therapeutic agents and has high permeability to tissues or tumors due to the use of antibody fragments and can be efficiently produced in host cells such as bacteria, have. |
| priorityDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 486.